In addition, Pat thinks then beginner investors should cultivate two important qualities: a healthy sense of skepticism and patience.
[text_ad]
Investors should approach all investments with a healthy sense of skepticism. This can help keep you out of fraudulent stocks that masquerade as high-quality stocks. It will also keep you out of legally operated, but poorly managed, companies that promise more than they can possibly deliver.
If you are a new investor, you should also realize that losing patience can cause you to sell your best choices right before a big rise. All too often, investors buy a promising stock just as it enters a period of price stagnation. Even the best-performing stocks run into these unpredictable phases from time to time. They move mainly sideways in a wide range for months or years before their next big rise begins. (Stock brokers often refer to these stocks as “dead money.”)
If you lack patience, you run a big risk of selling your best choices in the midst of one of these phases, prior to the next big move upward. If you lose patience and sell, you are particularly likely to do so in the low end of the trading range, when stock prices have weakened and confidence in the stock has waned.
[text_ad]
Some investors are reluctant to commit funds to Resources stocks right now, due to uncertainty about the impact of COVID-19 on the global economy....
“The sharp rise in stocks since March seems excessive to some. Stock prices are back up to their old highs, even though earnings remain well below past peaks.
Just remember…’A rising market climbs a wall of worry.’
This is one of those rare stock-market slogans than makes sense and fits on a T-shirt....
In the three months ended June 30, 2020, the company’s overall gold production fell 19.7%, to 331,064 ounces from 412,315 a year earlier....
My short answer(s): “No and no.” In fact, I can’t imagine a situation where I’d buy or recommend a SPAC (Special Purpose Acquisition Company), U.S....
Stryker’s investors benefit from its three business segments:
The Orthopaedics segment (32% of total revenue) sells products used in joint replacement surgeries and in trauma and extremities surgeries.
The Medical and Surgery segment (48%) sells surgical equipment and navigation instruments, endoscopic and communications systems, and devices used in a variety of medical specialties.
The Neurotechnology and Spine segment (20%) sells neurosurgical, neurovascular and spinal-implant devices.
Approximately 72% of Stryker’s revenue in each of the past three years has come from the U.S.
The company has actively acquired smaller firms over the past several years....
“The sharp rise in stocks since March seems excessive to some. Stock prices are back up to their old highs, even though earnings remain well below past peaks.
Just remember…'A rising market climbs a wall of worry.’
This is one of those rare stock-market slogans than makes sense and fits on a T-shirt....